Monoclonal gammopathy after intense induction immunosuppression in renal transplant patients

Nephrology Dialysis Transplantation

Volumn 11, Issue 12, 1996, Pages 2461-2465

  Passweg, J ^a   Thiel, G ^a   Bock, H A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Kidney transplantation; Monoclonal antibodies; Monoclonal gammopathy; Polyclonal antibodies; Prophylactic immunosuppression

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; OKT 3; PREDNISONE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; EARLY DIAGNOSIS; FOLLOW UP; HUMAN; IMMUNOELECTROPHORESIS; INCIDENCE; KAPOSI SARCOMA; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PRIORITY JOURNAL; RISK; RISK FACTOR;

EID: 0030466560     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027215     Document Type: Article

References (14)

1. Kyle RA. Plasma cell proliferative disorders. In: Hoffman R, Benz EJ, Schattl SJ, Furie B, Cohen HJ, eds. Hematology. Basic Principles and Practice. Churchill Livingstone, 1991; 1021-1038
2. Opelz G, Henderson R, for the collaborative transplant study. Incidence of non-Hodgkin's lymphoma in kidney and heart transplant recipients. Lancet 1993; 342: 1514
3. Cockfield SM, Preiksaitis J, Harvey E et al. Is sequential use of ALG and OKT3 in renal transplants associated with an increased incidence of fulminant post-transplant lymphoproliferative disorder? Transplant Proc 1991; 23: 1106
4. Swinnen LJ, Costanzo-Nordin MR, Fisher SG et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients, N Engl J Med 1990; 323: 1723
5. Bock HA, Gallati H, Zürcher R et al. A randomized prospective trial of prophylactic immunosuppression with ATG-Fresenius versus OKT3 after renal transplantation. Transplantation 1995; 59: 830-840
6. Passweg J, Bock HA, Tichelli A, Thiel G. 'Transient multiple myeloma' after intense immunosuppression in a renal transplant patient. Nephrol Dial Transplant 1993; 8: 1393-1394
7. Kyle RA, Lust JA. Monoclonal gammopathies of indetermined significance. Semin Hematol 1989; 26: 176
8. Crawford J, Eye MK, Cohen HJ. Evaluation of monoclonal gammopathies in the 'well' elderly. Am J Med 1987; 82: 39
9. Hestin D, Petitpain N, Mayeux D et al Influence of chronic rejection on the occurrence of monoclonal gammopathies in renal transplant patients. Clin Transplant 1993; 7: 59
10. Radl J, Valentijn RM, Haaijman JJ, Paul LC. Monoclonal gammapathies in patients undergoing immunosuppressive treatment after renal transplantation. Clin Immunol Immunapathol 1985; 37: 98
11. Stanko CK, Jeffrey JR, Rush DN. Monoclonal and multiclonal gammopathies after renal transplantation. Transplant Proc 1989; 21: 3330
12. Pollock CA, Mahony JF. Ibels LS et al. Immunoglobulin abnormalities in renal transplant recipients. Transplantation 1989; 47: 952
13. Gerritsen EJA, van Tol MJD, Lankester AC et al. Immunoglobulin levels and monoclonal gammopathies in children after bone marrow transplantation. Blood 1993; 82: 2393
14. Fischer G, Simon AM, Le Deist F, Blanche S, Griscelli C, Fischer A. Prospective study of the occurrence of monoclonal gammopathies following bone marrow transplantation in young children. Transplantation 1990; 49: 731